Related Experiment Video
Updated: May 5, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
Published on: July 16, 2012
Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
1Liver Research Unit, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taipei, Taiwan.
Insights
Hepatitis C virus (HCV) variants with altered peptide ligands emerged in patients who developed chronic infection, antagonizing cytotoxic T lymphocyte (CTL) activity. This suggests a limited T-cell receptor repertoire contributes to HCV chronicity.
Area of Science:
- Immunology
- Virology
- Hepatology
Background:
- High rates of chronic hepatitis C virus (HCV) infection are not fully explained by a multispecific cytotoxic T lymphocyte (CTL) response.
- Investigating the role of viral variants in CTL activity is crucial for understanding HCV chronicity.
Purpose of the Study:
- To examine the impact of HCV variants on CTL activity in patients with acute HCV infection.
- To elucidate the mechanisms underlying the development of chronic HCV infection.
Main Methods:
- Generation of CTL clones specific to a decapeptide epitope from HCV hypervariable region 1 in HLA-A2-positive patients.
- In vitro stimulation with synthetic peptides and examination of sequential epitope changes and CTL recognition.
Main Results:
- HCV variants with altered peptide ligands that antagonize CTL activity emerged in patients who developed chronic infection.
- No variants were observed in patients who recovered from acute HCV.
- CTL clones from chronic patients utilized specific T-cell receptor (TCR) genes (AV6 and BV17).
Conclusions:
- A narrow T-cell repertoire responding to a single viral peptide/HLA ligand may be involved in HCV chronicity.
- Emergence of HCV variants with altered peptide ligands acting as TCR antagonists, coupled with a limited TCR repertoire, may drive HCV chronicity.
Background & Aims:
High rate of chronicity after acute hepatitis C virus (HCV) infection cannot be explained in the presence of a multispecific cytotoxic T lymphocyte (CTL) response. The aim of this study was to investigate the effect of virus variants on CTL activity in patients in whom chronicity developed.
Methods:
CTL clones specific to a decapeptide epitope derived from hypervariable region 1 were generated from 5 HLA-A2-positive patients with acute hepatitis C by in vitro stimulation with synthetic peptides. The sequential change of this CTL epitope and its influence on the CTL recognition were examined.
Results:
Virus variants did not appear in 3 patients with recovery, whereas variants with altered peptide ligands capable of antagonizing CTL activity emerged rapidly in the remaining 2 patients in whom chronicity developed. Importantly, these HLA-A2-restricted, hypervariable region 1-specific CTL clones shared the use of T-cell receptor (TCR) genes AV6 and BV17.
Conclusions:
These data suggest that there is only a narrow T-cell repertoire responding to a single viral peptide/HLA ligand. The emergence of HCV variants with altered peptide ligands as TCR antagonists accompanied by a limited TCR repertoire may provide a mechanism for HCV chronicity.
Related Concept Videos
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
Subviral Agents
Cytomegalovirus Disease
Hepatitis
Viral Hepatitis I: Introduction

